Literature DB >> 31063753

The Extracellular Matrix Modulates the Metastatic Journey.

FuiBoon Kai1, Allison P Drain2, Valerie M Weaver3.   

Abstract

The extracellular matrix is perturbed in tumors. The tumor matrix promotes the growth, survival, and invasion of the cancer and modifies fibroblast and immune cell behavior to drive metastasis and impair treatment. Here, we discuss how the tumor matrix regulates metastasis by fostering tumor cell invasion into the stroma and migration toward the vasculature. We describe the role of the tumor matrix in cancer cell intravasation and vascular dissemination. We examine the impact of the matrix on disseminated tumor cell extravasation and on tumor dormancy and metastatic outgrowth. Finally, we discuss the clinical outcome of therapeutics that normalize tumor-matrix interactions.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  angiogenesis; dormancy; extracellular matrix; extravasation; integrin; intravasation; invasion; mechanics; mechanotransduction; metastasis; migration; outgrowth; pre-metastatic niche; tissue tension

Mesh:

Year:  2019        PMID: 31063753      PMCID: PMC6527347          DOI: 10.1016/j.devcel.2019.03.026

Source DB:  PubMed          Journal:  Dev Cell        ISSN: 1534-5807            Impact factor:   12.270


  126 in total

1.  Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice.

Authors:  Jean Albrengues; Mario A Shields; David Ng; Chun Gwon Park; Alexandra Ambrico; Morgan E Poindexter; Priya Upadhyay; Dale L Uyeminami; Arnaud Pommier; Victoria Küttner; Emilis Bružas; Laura Maiorino; Carmelita Bautista; Ellese M Carmona; Phyllis A Gimotty; Douglas T Fearon; Kenneth Chang; Scott K Lyons; Kent E Pinkerton; Lloyd C Trotman; Michael S Goldberg; Johannes T-H Yeh; Mikala Egeblad
Journal:  Science       Date:  2018-09-28       Impact factor: 47.728

2.  Allosteric inhibition of lysyl oxidase-like-2 impedes the development of a pathologic microenvironment.

Authors:  Vivian Barry-Hamilton; Rhyannon Spangler; Derek Marshall; Scott McCauley; Hector M Rodriguez; Miho Oyasu; Amanda Mikels; Maria Vaysberg; Haben Ghermazien; Carol Wai; Carlos A Garcia; Arleene C Velayo; Brett Jorgensen; Donna Biermann; Daniel Tsai; Jennifer Green; Shelly Zaffryar-Eilot; Alison Holzer; Scott Ogg; Dung Thai; Gera Neufeld; Peter Van Vlasselaer; Victoria Smith
Journal:  Nat Med       Date:  2010-09-05       Impact factor: 53.440

3.  Periostin promotes immunosuppressive premetastatic niche formation to facilitate breast tumour metastasis.

Authors:  Zhe Wang; Shanshan Xiong; Yubin Mao; Mimi Chen; Xiaohong Ma; Xueliang Zhou; Zhenling Ma; Fan Liu; Zhengjie Huang; Qi Luo; Gaoliang Ouyang
Journal:  J Pathol       Date:  2016-07-08       Impact factor: 7.996

4.  Matrix crosslinking forces tumor progression by enhancing integrin signaling.

Authors:  Kandice R Levental; Hongmei Yu; Laura Kass; Johnathon N Lakins; Mikala Egeblad; Janine T Erler; Sheri F T Fong; Katalin Csiszar; Amato Giaccia; Wolfgang Weninger; Mitsuo Yamauchi; David L Gasser; Valerie M Weaver
Journal:  Cell       Date:  2009-11-25       Impact factor: 41.582

5.  The propeptide domain of lysyl oxidase induces phenotypic reversion of ras-transformed cells.

Authors:  Amitha H Palamakumbura; Sébastien Jeay; Ying Guo; Nicole Pischon; Pascal Sommer; Gail E Sonenshein; Philip C Trackman
Journal:  J Biol Chem       Date:  2004-07-23       Impact factor: 5.157

6.  Normal and tumor-derived myoepithelial cells differ in their ability to interact with luminal breast epithelial cells for polarity and basement membrane deposition.

Authors:  Thorarinn Gudjonsson; Lone Rønnov-Jessen; René Villadsen; Fritz Rank; Mina J Bissell; Ole William Petersen
Journal:  J Cell Sci       Date:  2002-01-01       Impact factor: 5.285

7.  Matrix stiffness drives epithelial-mesenchymal transition and tumour metastasis through a TWIST1-G3BP2 mechanotransduction pathway.

Authors:  Spencer C Wei; Laurent Fattet; Jeff H Tsai; Yurong Guo; Vincent H Pai; Hannah E Majeski; Albert C Chen; Robert L Sah; Susan S Taylor; Adam J Engler; Jing Yang
Journal:  Nat Cell Biol       Date:  2015-04-20       Impact factor: 28.824

8.  Pirfenidone normalizes the tumor microenvironment to improve chemotherapy.

Authors:  Christiana Polydorou; Fotios Mpekris; Panagiotis Papageorgis; Chrysovalantis Voutouri; Triantafyllos Stylianopoulos
Journal:  Oncotarget       Date:  2017-04-11

9.  TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells.

Authors:  Sanjeev Mariathasan; Shannon J Turley; Dorothee Nickles; Alessandra Castiglioni; Kobe Yuen; Yulei Wang; Edward E Kadel; Hartmut Koeppen; Jillian L Astarita; Rafael Cubas; Suchit Jhunjhunwala; Romain Banchereau; Yagai Yang; Yinghui Guan; Cecile Chalouni; James Ziai; Yasin Şenbabaoğlu; Stephen Santoro; Daniel Sheinson; Jeffrey Hung; Jennifer M Giltnane; Andrew A Pierce; Kathryn Mesh; Steve Lianoglou; Johannes Riegler; Richard A D Carano; Pontus Eriksson; Mattias Höglund; Loan Somarriba; Daniel L Halligan; Michiel S van der Heijden; Yohann Loriot; Jonathan E Rosenberg; Lawrence Fong; Ira Mellman; Daniel S Chen; Marjorie Green; Christina Derleth; Gregg D Fine; Priti S Hegde; Richard Bourgon; Thomas Powles
Journal:  Nature       Date:  2018-02-14       Impact factor: 49.962

10.  Acute compressive stress activates RHO/ROCK-mediated cellular processes.

Authors:  Sarah T Boyle; Jasreen Kular; Max Nobis; Andrew Ruszkiewicz; Paul Timpson; Michael S Samuel
Journal:  Small GTPases       Date:  2018-02-17
View more
  105 in total

Review 1.  Modeling chemical effects on breast cancer: the importance of the microenvironment in vitro.

Authors:  Molly M Morgan; Linda A Schuler; Jordan C Ciciliano; Brian P Johnson; Elaine T Alarid; David J Beebe
Journal:  Integr Biol (Camb)       Date:  2020-03-06       Impact factor: 2.192

2.  Tension in tumour cells keeps metabolism high.

Authors:  Nadia M E Ayad; Valerie M Weaver
Journal:  Nature       Date:  2020-02       Impact factor: 49.962

Review 3.  The matrix in cancer.

Authors:  Thomas R Cox
Journal:  Nat Rev Cancer       Date:  2021-02-15       Impact factor: 60.716

4.  LAMB3 promotes tumour progression through the AKT-FOXO3/4 axis and is transcriptionally regulated by the BRD2/acetylated ELK4 complex in colorectal cancer.

Authors:  Zhehui Zhu; Jinglue Song; Yuegui Guo; Zhenyu Huang; Xiaojian Chen; Xuening Dang; Yuji Huang; Yuhan Wang; Weijun Ou; Yili Yang; Wei Yu; Chen-Ying Liu; Long Cui
Journal:  Oncogene       Date:  2020-05-12       Impact factor: 9.867

5.  Extracellular-Matrix-Anchored Click Motifs for Specific Tissue Targeting.

Authors:  Mary R Adams; Christopher T Moody; Jennifer L Sollinger; Yevgeny Brudno
Journal:  Mol Pharm       Date:  2019-12-27       Impact factor: 4.939

Review 6.  Unravelling tumour heterogeneity by single-cell profiling of circulating tumour cells.

Authors:  Laura Keller; Klaus Pantel
Journal:  Nat Rev Cancer       Date:  2019-08-27       Impact factor: 60.716

7.  Photocleavable Surfactant-Enabled Extracellular Matrix Proteomics.

Authors:  Samantha J Knott; Kyle A Brown; Harini Josyer; Austin Carr; David Inman; Song Jin; Andreas Friedl; Suzanne M Ponik; Ying Ge
Journal:  Anal Chem       Date:  2020-11-24       Impact factor: 6.986

8.  Progesterone Receptors Promote Quiescence and Ovarian Cancer Cell Phenotypes via DREAM in p53-Mutant Fallopian Tube Models.

Authors:  Laura J Mauro; Megan I Seibel; Caroline H Diep; Angela Spartz; Carlos Perez Kerkvliet; Hari Singhal; Elizabeth M Swisher; Lauren E Schwartz; Ronny Drapkin; Siddharth Saini; Fatmata Sesay; Larisa Litovchick; Carol A Lange
Journal:  J Clin Endocrinol Metab       Date:  2021-06-16       Impact factor: 5.958

9.  Cytotoxic lymphocytes target characteristic biophysical vulnerabilities in cancer.

Authors:  Maria Tello-Lafoz; Katja Srpan; Elisa E Sanchez; Jing Hu; Jan Remsik; Yevgeniy Romin; Annalisa Calò; Douglas Hoen; Umeshkumar Bhanot; Luc Morris; Adrienne Boire; Katharine C Hsu; Joan Massagué; Morgan Huse; Ekrem Emrah Er
Journal:  Immunity       Date:  2021-03-22       Impact factor: 31.745

Review 10.  Visualizing cancer extravasation: from mechanistic studies to drug development.

Authors:  Xiao Cheng; Ke Cheng
Journal:  Cancer Metastasis Rev       Date:  2020-11-06       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.